February 2, 2023
Chuikyo Drug Pricing Subcommittee Meeting on Feb. 1 An all-powerful Japanese reimbursement policy panel on February 1 agreed to use multiple medicines as comparators for the initial pricing of Shionogi’s oral antiviral Xocova (ensitrelvir), such as other COVID-19 therapies and...read more